The findings revealed a remarkable upregulation of SLC16A3 expression in various cancer types, including ESCA, BLCA, CESC, BRCA, CHOL, KIRC, HNSC, KIRP, LIHC, LUSC, LUAD, THCA, STAD, and UCEC. This evidence concerns the gene SLC16A3 and cancer.